{"id":"https://openalex.org/W3217029326","doi":"https://doi.org/10.1161/circ.144.suppl_1.10160","title":"Abstract 10160: Population Eligible for PCSK9i in Spain: A Real-World Analysis","display_name":"Abstract 10160: Population Eligible for PCSK9i in Spain: A Real-World Analysis","publication_year":2021,"publication_date":"2021-11-16","ids":{"openalex":"https://openalex.org/W3217029326","doi":"https://doi.org/10.1161/circ.144.suppl_1.10160","mag":"3217029326"},"language":"en","primary_location":{"id":"doi:10.1161/circ.144.suppl_1.10160","doi":"https://doi.org/10.1161/circ.144.suppl_1.10160","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circ.144.suppl_1.10160","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040616808","display_name":"Juan Cos\u00edn-Sales","orcid":"https://orcid.org/0000-0002-4249-557X","observed_orcids":["https://orcid.org/0000-0002-4249-557X"]},"institutions":[{"id":"https://openalex.org/I4210119293","display_name":"Hospital Arnau de Vilanova","ror":"https://ror.org/02s7fkk92","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210119293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Juan Cosin Sales","raw_affiliation_strings":["Servicio de Cardiolog\u00eda, Hosp Arnau de Vilanova, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servicio de Cardiolog\u00eda, Hosp Arnau de Vilanova, Valencia, Spain","institution_ids":["https://openalex.org/I4210119293"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086549151","display_name":"Eduard Sidelnikov","orcid":"https://orcid.org/0000-0001-9384-2255","observed_orcids":["https://orcid.org/0000-0001-9384-2255"]},"institutions":[{"id":"https://openalex.org/I4210139000","display_name":"Amgen (Switzerland)","ror":"https://ror.org/045wjte67","country_code":"CH","type":"company","lineage":["https://openalex.org/I1320553840","https://openalex.org/I4210139000"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Eduard Sidelnikov","raw_affiliation_strings":["Amgen (Europe) GmbH, Rotkreuz, Switzerland","Eduard Sidelnikov Amgen (Europe) GmbH, Rotkreuz, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen (Europe) GmbH, Rotkreuz, Switzerland","institution_ids":["https://openalex.org/I4210139000"]},{"raw_affiliation_string":"Eduard Sidelnikov Amgen (Europe) GmbH, Rotkreuz, Switzerland","institution_ids":["https://openalex.org/I4210139000"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059613436","display_name":"Santiago Villamayor Galli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Santiago Villamayor Galli","raw_affiliation_strings":["Amgen Spain, Barcelona, Spain","Santiago Villamayor Galli Amgen Spain, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Spain, Barcelona, Spain","institution_ids":[]},{"raw_affiliation_string":"Santiago Villamayor Galli Amgen Spain, Barcelona, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069226692","display_name":"M\u00edriam Fern\u00e1ndez Delgado","orcid":"https://orcid.org/0009-0002-4545-5300","observed_orcids":["https://orcid.org/0009-0002-4545-5300"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Miriam Fernandez Delgado","raw_affiliation_strings":["Amgen Spain, Bercelona, Spain","Miriam Fernandez Delgado Amgen Spain, Bercelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Spain, Bercelona, Spain","institution_ids":[]},{"raw_affiliation_string":"Miriam Fernandez Delgado Amgen Spain, Bercelona, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005751296","display_name":"Elena Torres Romero","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elena Torres Romero","raw_affiliation_strings":["IQVIA, Barcelona, Spain","Elena Torres Romero IQVIA, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IQVIA, Barcelona, Spain","institution_ids":[]},{"raw_affiliation_string":"Elena Torres Romero IQVIA, Barcelona, Spain","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091748049","display_name":"Alberto Zamora","orcid":"https://orcid.org/0000-0001-6907-0654","observed_orcids":["https://orcid.org/0000-0001-6907-0654"]},"institutions":[{"id":"https://openalex.org/I4405267146","display_name":"Consorci Corporaci\u00f3 de Salut del Maresme i la Selva","ror":"https://ror.org/01ct41160","country_code":"ES","type":"government","lineage":["https://openalex.org/I4405267146"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Alberto Zamora","raw_affiliation_strings":["Unidad de Riesgo Vascular y L\u00edpidos Corporaci\u00f3 de Salut del Maresme i la Selva, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unidad de Riesgo Vascular y L\u00edpidos Corporaci\u00f3 de Salut del Maresme i la Selva, Spain","institution_ids":["https://openalex.org/I4405267146"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"144","issue":"Suppl_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pcsk9-inhibitors","display_name":"PCSK9 inhibitors","score":0.9959999918937683},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.5910000205039978},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.7580000162124634},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.8920000195503235},{"id":"https://openalex.org/keywords/ezetimibe","display_name":"ezetimibe","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.531000018119812},{"id":"https://openalex.org/keywords/ldl-c-target-attainment","display_name":"LDL-C goal attainment","score":0.4480000138282776},{"id":"https://openalex.org/keywords/primary-care","display_name":"primary care","score":0.6010000109672546},{"id":"https://openalex.org/keywords/spain","display_name":"Spain","score":0.5770000219345093},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.32600000500679016},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.6840000152587891},{"id":"https://openalex.org/keywords/ischemic-stroke","display_name":"ischemic stroke","score":0.9399999976158142},{"id":"https://openalex.org/keywords/peripheral-arterial-disease","display_name":"peripheral arterial disease","score":0.9229999780654907},{"id":"https://openalex.org/keywords/unstable-angina","display_name":"unstable angina","score":0.8180000185966492},{"id":"https://openalex.org/keywords/transient-ischemic-attack","display_name":"transient ischemic attack","score":0.9739999771118164}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9678754806518555},{"id":"https://openalex.org/C2778657065","wikidata":"https://www.wikidata.org/wiki/Q417997","display_name":"Ezetimibe","level":3,"score":0.9012527465820312},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.6309831738471985},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.6253641247749329},{"id":"https://openalex.org/C2777785093","wikidata":"https://www.wikidata.org/wiki/Q2032041","display_name":"Unstable angina","level":3,"score":0.6205210089683533},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5962740778923035},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5565012693405151},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5024845600128174},{"id":"https://openalex.org/C195910791","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Medical record","level":2,"score":0.4918191730976105},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.48126834630966187},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.45044106245040894},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3344748020172119},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1161/circ.144.suppl_1.10160","doi":"https://doi.org/10.1161/circ.144.suppl_1.10160","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circ.144.suppl_1.10160","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4311667122","https://openalex.org/W3048421174","https://openalex.org/W2794985857","https://openalex.org/W2888448825","https://openalex.org/W4401745617","https://openalex.org/W2995769681","https://openalex.org/W4388596415","https://openalex.org/W2998463961","https://openalex.org/W4393005163","https://openalex.org/W2992678675"],"abstract_inverted_index":{"Background:":[0],"Cardiovascular":[1],"(CV)":[2],"diseases":[3],"are":[4],"the":[5,49,64,104,115,142,156,175,238,320],"leading":[6],"cause":[7],"of":[8,23,96,146,177,187,227,268,270,290,295,314,319],"mortality":[9],"globally.":[10],"Reducing":[11],"low-density":[12],"lipoprotein":[13],"cholesterol":[14,100],"(LDL-C)":[15],"is":[16],"a":[17,32,40],"proven":[18],"strategy":[19],"to":[20,30,111],"decrease":[21],"risk":[22,294],"acute":[24],"CV":[25],"events.":[26],"The":[27,119],"study":[28,43,105,120,143,157],"aimed":[29],"estimate":[31],"PCSK9i-eligible":[33],"population":[34,144],"in":[35,63,103,284,298],"Spain.":[36],"Methods:":[37],"We":[38],"conducted":[39],"retrospective":[41],"cohort":[42,300],"based":[44],"on":[45,190,199,210,215,242,255,262],"real-world":[46],"data":[47],"from":[48,114],"IQVIA":[50],"Spanish":[51,342],"Electronic":[52],"Medical":[53],"Records":[54],"primary":[55],"care":[56],"database.":[57],"Adult":[58],"(\u226518":[59],"y.o.)":[60],"patients":[61,147,188,229,254,271,291,321],"registered":[62],"database":[65],"between":[66],"2014":[67],"and":[68,90,106,134,170,213,245,260],"2020,":[69],"diagnosed":[70,164],"with":[71,91,165,168,172,249,329],"myocardial":[72],"infarction":[73],"(MI),":[74],"unstable":[75],"angina":[76],"(UA),":[77],"ischemic":[78,82],"stroke":[79],"(IS),":[80],"transient":[81],"attack":[83],"(TIA)":[84],"or":[85,98,206,222],"peripheral":[86],"artery":[87],"disease":[88],"(PAD)":[89],"at":[92,292],"least":[93],"1":[94],"measurement":[95],"LDL-C":[97,136,180,231,304,323],"total":[99,267],"were":[101,132,163,189,198],"included":[102,121],"followed":[107,252],"up":[108,110],"for":[109,282,312,338],"12":[112],"months":[113,183],"initial":[116],"diagnosis.":[117],"Results:":[118],"9,516":[122],"patients;":[123],"mean":[124,135],"(SD)":[125],"age":[126],"was":[127,137,237],"67.7":[128],"(12.5)":[129],"years,":[130],"63.9%":[131],"male":[133],"117.3":[138],"(38.8)":[139],"mg/dL.":[140],"In":[141],"28.5%":[145],"suffered":[148],"an":[149,276],"MI":[150],"as":[151],"most":[152],"severe":[153],"event":[154],"during":[155],"period,":[158],"10.0%":[159],"had":[160,275],"UA,":[161],"18.7%":[162],"IS,":[166],"13.6%":[167],"TIA,":[169],"29.3%":[171],"PAD.":[173],"At":[174],"time":[176],"last":[178],"available":[179],"assessment":[181],"(\u22653":[182],"after":[184],"diagnosis),":[185],"64.4%":[186],"lipid":[191],"lowering":[192],"therapy":[193],"(LLT).":[194],"Of":[195],"those,":[196],"45.4%":[197],"high-intensity":[200,243],"LLT":[201,217,274,332],"(high-intensity":[202],"statins":[203,244,258],"with/without":[204],"ezetimibe":[205,220,250],"PCSK9":[207],"inhibitors),":[208],"46.9%":[209],"moderate-intensity":[211],"statins,":[212,219],"7.7%":[214],"low-Intensity":[216],"(low-intensity":[218],"alone":[221],"non-statin":[223],"LLT).":[224],"Overall,":[225],"12.9%":[226],"treated":[228,328],"achieved":[230],"levels":[232],"<55":[233,305],"mg/dL;":[234],"this":[235],"proportion":[236],"highest":[239],"among":[240],"those":[241,261],"any":[246],"statin":[247],"combined":[248],"(63.2%),":[251],"by":[253,308],"moderate":[256],"intensity":[257],"(32.6%)":[259],"low-intensity":[263],"LLTs":[264],"(3.1%).":[265],"A":[266],"17.1%":[269],"receiving":[272],"optimized":[273],"LDL-C>100":[277],"mg/dL":[278,306,325],"(LDL-C":[279],"reimbursement":[280,343],"threshold":[281],"PCSK9i":[283,340],"Spain).":[285],"Conclusions:":[286],"More":[287,316],"than":[288,317],"85%":[289],"very-high":[293],"cardiovascular":[296],"events":[297],"our":[299],"do":[301],"not":[302],"achieve":[303],"recommended":[307],"2019":[309],"ESC/EAS":[310],"guidelines":[311],"management":[313],"dyslipidemia.":[315],"17%":[318],"have":[322],">100":[324],"despite":[326],"being":[327],"maximally":[330],"tolerated":[331],"and,":[333],"therefore,":[334],"would":[335],"be":[336],"eligible":[337],"using":[339],"within":[341],"criteria.":[344]},"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2021-12-06T00:00:00"}